BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Rocuronium

An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary structure and is a weaker nicotinic antagonist than PANCURONIUM.

298+ PubMed studies analyzed · 80 RCTs · Evidence Score: 58

Research Domains

Rocuronium has been studied across 14 research domains including 😴 Sleep, 💊 Pain, 💪 Strength & Power, 🧠 Focus & Attention, 🫁 Liver & Detox. The primary research focus is 😴 Sleep with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rocuronium, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

dofetilide
2 shared targets
Carvedilol
2 shared targets
Aripiprazole
2 shared targets
Amitriptyline
2 shared targets
Disulfiram
2 shared targets
smilax
2 shared targets
artemisia
2 shared targets
artemisia
2 shared targets
cimicifuga
2 shared targets
morinda
2 shared targets
Loading evidence profile...

This evidence profile for Rocuronium is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.